Goldman Sachs’s new fund—its first dedicated to life sciences—will focus on early- to mid-stage therapeutics companies with multiple assets. Genetic medicine, cell therapy, immunotherapy, and artificial intelligence are among the areas of investment interest for the firm.
Four years after a private equity acquisition took Parexel private, the contract research organization is being acquired by two private equity firms for $8.5 billion. It’s the latest in a series of acquisitions to hit the CRO sector this year.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
The filing comes one week after the company, founded earlier this year with a $300 million Series A round by two former Kite executives, raised $120 million in a private financing.
The Venus P-valve pulmonary replacement has already been implanted in more than 40 patients, and the current goal is to win CE Mark approval. They will reportedly be enrolling patients to accomplish this in the early half of the year.
Privia Health, which seeks to help physician practices remain independent in lieu of massive consolidation occurring in healthcare, is significantly boosting those efforts with a $400 million national expansion. Backed by an investor group led by an affiliate of Goldman Sachs, the Virginia-based physician practice management group said the expansion is a direct result of the […]
SeeChange Health has won a Red Herring Top 100 North America Award. The award recognizes private companies from North America for innovation and new technology in their respective industries. SeeChange Health offers Health Insurance and Health Solutions while encouraging people to keep an active role in managing their health. In addition to paying customers’ medical bills, […]
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
It’s been a while since we could get excited about implantable cardioverter defibrillators (ICDs), the watch-sized devices that shock an irregular heart back into rhythm. The device that helped launched the dominance of Minnesota’s medical device industry barely registers a yawn today. ICDs are what we call a “mature” industry, growing around 4 to 6 […]
Michael DeMane is finally a CEO. The former chief operating officer at Medtronic Inc. (NYSE: MDT), once thought to be a top candidate to lead the world’s largest medical device firm, recently joined Lanx Inc. as chairman and CEO. The company, based in Broomfield, Colo., makes devices for spinal surgeries. Investors include Chicago Growth Partners, […]
John Paulson, whose hedge fund is one of Boston Scientific Corp.’s (NYSE:BSX) biggest stakeholders, is embroiled in the Securities & Exchange Commission’s indictment of Goldman Sachs Co., accused of “fraudulent misconduct” in an alleged scheme to mislead the public over the sub-prime mortgage crisis. The SEC filed a civil suit against Goldman Sachs April 16, […]